Compounds > carbogen
Page last updated: 2024-08-24

carbogen and Oropharyngeal Neoplasms

carbogen has been researched along with Oropharyngeal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bussink, J; Folkes, LK; Kaanders, JH; Stratford, MR; van der Kogel, AJ1
Kaanders, JH; Marres, HA; Pop, LA; van Daal, WA; van der Kogel, AJ; van der Maazen, RW1

Other Studies

2 other study(ies) available for carbogen and Oropharyngeal Neoplasms

ArticleYear
Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2002, Volume: 63, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma; Domperidone; Dose Fractionation, Radiation; Female; Humans; Male; Middle Aged; Nausea; Niacinamide; Oropharyngeal Neoplasms; Oxygen; Radiation-Sensitizing Agents; Vomiting

2002
Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1995, Volume: 37, Issue:3

    Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma, Mucoepidermoid; Carcinoma, Squamous Cell; Feasibility Studies; Female; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Niacinamide; Oropharyngeal Neoplasms; Oxygen; Palliative Care; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy Dosage

1995